Page last updated: 2024-10-28

hydroxychloroquine and Osteoporosis, Postmenopausal

hydroxychloroquine has been researched along with Osteoporosis, Postmenopausal in 2 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Osteoporosis, Postmenopausal: Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.

Research Excerpts

ExcerptRelevanceReference
"FFA is an increasingly common form of scarring hair loss, but the origin remains unknown."1.39Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University. ( Bazakas, A; Ladizinski, B; Olsen, EA; Selim, MA, 2013)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ladizinski, B1
Bazakas, A1
Selim, MA1
Olsen, EA1
Lakshminarayanan, S1
Walsh, S1
Mohanraj, M1
Rothfield, N1

Other Studies

2 other studies available for hydroxychloroquine and Osteoporosis, Postmenopausal

ArticleYear
Frontal fibrosing alopecia: a retrospective review of 19 patients seen at Duke University.
    Journal of the American Academy of Dermatology, 2013, Volume: 68, Issue:5

    Topics: 5-alpha Reductase Inhibitors; Adult; Aged; Alopecia; Anti-Bacterial Agents; Azasteroids; Cicatrix; D

2013
Factors associated with low bone mineral density in female patients with systemic lupus erythematosus.
    The Journal of rheumatology, 2001, Volume: 28, Issue:1

    Topics: Absorptiometry, Photon; Activities of Daily Living; Adolescent; Adult; Aged; Bone Density; Child; Co

2001